SCHEMBL27979684

SCHEMBL27979684

Cn1c2ccccc2c2cc(C=O)ncc21

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR3 P46089 1/20 0.50
KDM4E B2RXH2 4/20 0.45
MAPT P10636 2/20 0.44
GABRP O00591 2/20 0.44
GABRD O14764 2/20 0.44
GABRA1 P14867 2/20 0.44
GABRB1 P18505 2/20 0.44
GABRG2 P18507 2/20 0.44
GABRB3 P28472 2/20 0.44
GABRA5 P31644 2/20 0.44
GABRA3 P34903 2/20 0.44
GABRA2 P47869 2/20 0.44
GABRB2 P47870 2/20 0.44
GABRA4 P48169 2/20 0.44
GABRE P78334 2/20 0.44
GABRA6 Q16445 2/20 0.44
GABRG1 Q8N1C3 2/20 0.44
GABRG3 Q99928 2/20 0.44
GABRQ Q9UN88 2/20 0.44
ALDH1A1 P00352 4/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27979704 0.81 MEN1 (0.48) MAPTHPGDMEN1HTTKMT2A
SCHEMBL2459822 0.81 PTGER4 (0.59) KDM4EMAPTALDH1A1HPGDHSD17B10
SCHEMBL27979932 0.79 CNR2 (0.56) ALDH1A1PTGER4
SCHEMBL27979719 0.77 ALDH1A1 (0.52) KDM4EMAPTALDH1A1HPGDHSD17B10
SCHEMBL3337353 0.77 GPR3 (0.57) GPR3KDM4EMAPTGABRPGABRD
SCHEMBL27979723 0.76 CYP19A1 (0.57) KDM4EMAPTALDH1A1HPGDHSD17B10
SCHEMBL3339641 0.76 GPR3 (0.55) GPR3KDM4EMAPTGABRPGABRD
SCHEMBL27979888 0.76 GPR3 (0.55) GPR3KDM4EMAPTGABRPGABRD
SCHEMBL27979880 0.74 SIGMAR1 (0.45) PTGER4
SCHEMBL23373487 0.74 GPR3 (0.53) GPR3KDM4EMAPTGABRPGABRD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104177377-A 3-Position diamine beta-carboline alkali compound, and preparation method, medicinal composition and use thereof XINJIANG HUASHIDAN PHARMACEUTICAL RES CO LTD 2014-12-03 CN disclosed